基本信息
浏览量:0
职业迁徙
个人简介
Biography
My work focuses on the etiology of autoimmune diseases affecting millions of individuals in the world by identifying molecules and pathways involved in the establishment of B-cell tolerance through the investigation of rare patients with primary immunodeficiency (PID), enrolled at Yale and through an international network.
Patients with PID provide opportunities to study the impact of specific gene defects on the regulation of B-cell tolerance and the removal of developing autoreactive B cells in humans. Using a RT-PCR based strategy that allows us to assess the frequency of autoreactive B cells, we found that alterations in B-cell receptor (BCR) signaling in patients lacking functional BTK or CD19, or mutations in molecules mediating TLR signaling such as TACI, IRAK4, MyD88 as well as in adenosine deaminase (ADA) and activation-induced cytidine deaminase (AID) all result in a defective central checkpoint and a failure to counterselect developing autoreactive B cells in the bone marrow. Interestingly, successful gene therapy in ADA-deficient patients results in the restoration of early B-cell tolerance checkpoints, revealing that appropriate regiments could correct B-cell selection impairments characteristic of many patients with autoimmune conditions. Our investigations also revealed that central B-cell tolerance defects are primary to many autoimmune diseases including rheumatoid arthritis, type 1 diabetes and systemic lupus erythematosus and can result from genetic polymorphisms such as the R620W PTPN22 risk allele associated with all these diseases and that was reported to alter BCR signaling important for the regulation of this checkpoint.
In contrast, most patients with multiple sclerosis only suffer from specific defects of their peripheral B-cell tolerance checkpoint that likely result from abnormal regulatory T cells, which normally control this second B-cell selection step in the periphery. Regardless of which early B-cell tolerance checkpoint is defective in patients with autoimmune diseases, all these patients are characterized by the accumulation of autoreactive clones in their mature naïve B cell compartment, which may contribute to the development of autoimmunity by increasing the frequency of B cells presenting self-antigens. Understanding the etiology of autoimmunity is the first step toward effective treatment, therapy and ultimately, cure.
My work focuses on the etiology of autoimmune diseases affecting millions of individuals in the world by identifying molecules and pathways involved in the establishment of B-cell tolerance through the investigation of rare patients with primary immunodeficiency (PID), enrolled at Yale and through an international network.
Patients with PID provide opportunities to study the impact of specific gene defects on the regulation of B-cell tolerance and the removal of developing autoreactive B cells in humans. Using a RT-PCR based strategy that allows us to assess the frequency of autoreactive B cells, we found that alterations in B-cell receptor (BCR) signaling in patients lacking functional BTK or CD19, or mutations in molecules mediating TLR signaling such as TACI, IRAK4, MyD88 as well as in adenosine deaminase (ADA) and activation-induced cytidine deaminase (AID) all result in a defective central checkpoint and a failure to counterselect developing autoreactive B cells in the bone marrow. Interestingly, successful gene therapy in ADA-deficient patients results in the restoration of early B-cell tolerance checkpoints, revealing that appropriate regiments could correct B-cell selection impairments characteristic of many patients with autoimmune conditions. Our investigations also revealed that central B-cell tolerance defects are primary to many autoimmune diseases including rheumatoid arthritis, type 1 diabetes and systemic lupus erythematosus and can result from genetic polymorphisms such as the R620W PTPN22 risk allele associated with all these diseases and that was reported to alter BCR signaling important for the regulation of this checkpoint.
In contrast, most patients with multiple sclerosis only suffer from specific defects of their peripheral B-cell tolerance checkpoint that likely result from abnormal regulatory T cells, which normally control this second B-cell selection step in the periphery. Regardless of which early B-cell tolerance checkpoint is defective in patients with autoimmune diseases, all these patients are characterized by the accumulation of autoreactive clones in their mature naïve B cell compartment, which may contribute to the development of autoimmunity by increasing the frequency of B cells presenting self-antigens. Understanding the etiology of autoimmunity is the first step toward effective treatment, therapy and ultimately, cure.
研究兴趣
论文共 169 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Dana Ghergus,Mickael Martin,Anne-Marie Knapp,Fabien Delmotte, Aurelie Joublin-Delavat,Sophie Jung,Jean-Nicolas Schickel, Isabelle Mendel, Arnaud Dupuis,Bernard Drenou,Herve Ghesquieres,Gilles Salles,
AMERICAN JOURNAL OF HEMATOLOGYno. 1 (2024): 48-56
Elif Çakan,Marie Dominique Ah Kioon,Yolanda Garcia-Carmona,Salomé Glauzy,David Oliver,Natsuko Yamakawa, Andrea Vega Loza,Yong Du,Jean-Nicolas Schickel,Joshua M Boeckers,Chao Yang, Alessia Baldo,
The Journal of experimental medicineno. 12 (2023)
引用1浏览0WOS引用
1
0
Marie Dominique Ah Kioon, Elif Cakan,Yolanda Garcia-Carmona,Charlotte Cunningham-Rundles,Eric Meffre, Franck J. Barrat
Journal of Immunologyno. 1 (2023): 247.10-247.10
Adriana A. de Jesus,Guibin Chen,Dan Yang,Tomas Brdicka,Natasha M. Ruth,David Bennin, Dita Cebecauerova,Hana Malcova, Helen Freeman,Neil Martin,Karel Svojgr,Murray H. Passo,
Allan Feng,Emily Y Yang, Andrew Reese Moore,Shaurya Dhingra,Sarah Esther Chang,Xihui Yin,Ruoxi Pi,Elisabeth Km Mack, Sara Völkel,Reinhard Geßner,Margrit Gündisch,Andreas Neubauer,
bioRxiv (Cold Spring Harbor Laboratory) (2023)
引用0浏览0引用
0
0
A. Mirousea, F. Naz Cemre Kalayci, M. Maienschein-Cline, Y. Le Guen, E. Sefik, F. R. Delmotte, J. W. Chen, J. Barnas, M. Clark, R. A. Flavell, J. H. Anolik,E. Meffre
REVUE DE MEDECINE INTERNE (2023): A319-A320
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn